highly significantp -value of <0.001
Cholangiocarcinoma was diagnosed in 15.2% of the previous sphincterotomy group, 9.3% of the sphincterotomy and stent group, and 6.1% of the ERCP-naïve group, with a highly significant p -value of <0.001.
Cholangiocarcinoma was diagnosed in 15.2% of the previous sphincterotomy group, 9.3% of the sphincterotomy and stent group, and 6.1% of the ERCP-naïve group, with a highly significant p -value of <0.001.